On March 4, 2025, our CEO/CSO, Dr. Tamaki, will deliver a presentation at the 36th Biomedical Research Meeting. This online event, conducted in Japanese, is organized by the Japanese Society for Bioinformatics in collaboration with the Urban Innovation Institute and will commence at 1:30 PM JST.

At 2:50 PM, Dr. Tamaki will present a talk titled “Antibody Drug Discovery Leveraging Evolutionary Molecular Engineering and Large Language Models”. He will introduce MOLCURE’s latest research on integrating cutting-edge AI technologies with evolutionary molecular engineering to design and optimize high-performance antibodies.
For more details on the event and registration, please visit the official website (link). We look forward to your participation.